Fennec Pharmaceuticals Inc.
FENC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001211583
In the last 90 days, Fennec Pharmaceuticals Inc. insiders filed 0 open-market purchases and 6 sales; 105 institutions reported holding it in 13F filings for Q2 2026, worth $175.1M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Fennec Pharmaceuticals Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- −7 vs. Q2 2021
- Shares held
- 11.6M
- −429.3K (−3.6%) vs. Q2 2021
- Total value
- $109.7M
- +$21.7M (+24.6%) vs. Q2 2021
- New holders
- 3
- 6 more added
- Sold out
- 10
- 13 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FENC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 105 | $175.1M |
| Q1 2026 | 90 | $99.6M |
| Q4 2025 | 96 | $119.6M |
| Q3 2025 | 84 | $129.8M |
| Q2 2025 | 78 | $112.9M |
| Q1 2025 | 68 | $81.6M |
| Q4 2024 | 64 | $101.4M |
| Q3 2024 | 63 | $74.6M |
| Q2 2024 | 64 | $87.7M |
| Q1 2024 | 65 | $161.1M |
| Q4 2023 | 56 | $168.4M |
| Q3 2023 | 55 | $107.6M |
| Q2 2023 | 56 | $124.5M |
| Q1 2023 | 54 | $108.5M |
| Q4 2022 | 43 | $119.5M |
| Q3 2022 | 31 | $92.1M |
| Q2 2022 | 28 | $63.2M |
| Q1 2022 | 28 | $64.1M |
| Q4 2021 | 30 | $49.9M |
| Q3 2021 | 32 | $109.7M |
| Q2 2021 | 39 | $88.0M |
| Q1 2021 | 53 | $89.3M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Fennec Pharmaceuticals Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Southpoint Capital Advisors LP | 4,077,214 | $38.4M | 0.82% | 00.0% | Unchanged |
| Sonic Fund II, L.P. | 2,407,357 | $22.7M | 12.81% | −25,873−1.1% | Reduced |
| Avoro Capital Advisors LLC | 1,670,000 | $15.7M | 0.25% | 00.0% | Unchanged |
| 683 Capital Management, LLC | 1,110,000 | $10.5M | 0.54% | 00.0% | Unchanged |
| Solas Capital Management, LLC | 867,857 | $8.18M | 5.69% | 00.0% | Unchanged |
| DG Capital Management, LLC | 618,451 | $5.83M | 1.19% | +29,678+5.0% | Added |
| Millennium Management LLC | 257,621 | $2.43M | 0.00% | −147,151−36.4% | Reduced |
| Harbert Fund Advisors, Inc. | 174,750 | $1.65M | 0.85% | +53,899+44.6% | Added |
| Ergoteles LLC | 91,434 | $861.0K | 0.03% | −906−1.0% | Reduced |
| BlackRock Inc. | 57,321 | $541.0K | 0.00% | −5,166−8.3% | Reduced |
| HRT Financial LP | 55,935 | $526.0K | 0.00% | −6,055−9.8% | Reduced |
| Morgan Stanley | 40,983 | $386.0K | 0.00% | −2,447−5.6% | Reduced |
| Valley Forge Investment Consultants Inc Adv | 40,000 | $377.0K | 0.20% | 00.0% | Unchanged |
| Russell Investments Group, Ltd. | 31,728 | $298.0K | 0.00% | −80,856−71.8% | Reduced |
| Hartford Financial Management Inc. | 28,848 | $272.0K | 0.07% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 26,942 | $254.0K | 0.00% | +12,544+87.1% | Added |
| Geode Capital Management, LLC | 19,909 | $187.0K | 0.00% | +1,983+11.1% | Added |
| Belvedere Trading LLC | 17,790 | $155.0K | 0.04% | +17,790 | New |
| Goldman Sachs Group Inc | 13,432 | $127.0K | 0.00% | +34+0.3% | Added |
| Advisor Group Holdings, Inc. | 12,370 | $117.0K | 0.00% | 00.0% | Unchanged |
| Parametric Portfolio Associates LLC | 10,994 | $104.0K | 0.00% | −11,441−51.0% | Reduced |
| Ancora Advisors, LLC | 6,000 | $57.0K | 0.00% | +6,000 | New |
| Bank of America Corp | 4,847 | $45.0K | 0.00% | +392+8.8% | Added |
| Barclays PLC | 2,648 | $25.0K | 0.00% | −346−11.6% | Reduced |
| Group One Trading, L.P. | 1,600 | $15.0K | 0.00% | +1,600 | New |
| Wells Fargo & Company | 1,400 | $13.0K | 0.00% | 00.0% | Unchanged |
| Wealth Quarterback LLC | 1,000 | $10.0K | 0.01% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 256 | $2.41K | 0.00% | −128−33.3% | Reduced |
| UBS Group AG | 64 | $1.00K | 0.00% | −58,922−99.9% | Reduced |
| Royal Bank of Canada | 94 | $1.00K | 0.00% | −319−77.2% | Reduced |
| Simplex Trading, LLC | 241 | $1.00K | 0.00% | 00.0% | Unchanged |
| Toronto Dominion Bank | 23 | $0 | 0.00% | −32−58.2% | Reduced |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −68,724−100.0% | Sold out |
| Tibra Equities Europe Ltd | 0 | $0 | 0.00% | −46,300−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −24,278−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −20,284−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −20,021−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −17,115−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −13,454−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −3,068−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −198−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −100−100.0% | Sold out |